142 related articles for article (PubMed ID: 19273141)
1. Cell signaling modifiers for molecular targeted therapy in ATLL.
Mori N
Front Biosci (Landmark Ed); 2009 Jan; 14(4):1479-89. PubMed ID: 19273141
[TBL] [Abstract][Full Text] [Related]
2. Molecular insight into the study of adult T-cell leukemia/lymphoma (ATLL): Ten-year studies on HTLV-1 associated diseases in an endemic region.
Ashrafi F; Rahimzada M; Parandi M; Mirhosseini A; Mashkani B; Ahmadi Ghezeldasht S; Soltani A; Rafatpanah H; Mosavat A; Abdolrahim Rezaee S
Gene; 2022 Dec; 847():146885. PubMed ID: 36108787
[TBL] [Abstract][Full Text] [Related]
3. Rigosertib is more potent than wortmannin and rapamycin against adult T-cell leukemia-lymphoma.
Ghorbanzadeh Neghab M; Jalili-Nik M; Soltani A; Afshari AR; Hassanian SM; Rafatpanah H; Rezaee SA; Sadeghnia HR; Ataei Azimi S; Mashkani B
Biofactors; 2023; 49(6):1174-1188. PubMed ID: 37345860
[TBL] [Abstract][Full Text] [Related]
4. Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma.
Rauch DA; Olson SL; Harding JC; Sundaramoorthi H; Kim Y; Zhou T; MacLeod AR; Challen G; Ratner L
Retrovirology; 2020 Aug; 17(1):27. PubMed ID: 32859220
[TBL] [Abstract][Full Text] [Related]
5. Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2017 Aug; 51(2):633-643. PubMed ID: 28586006
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.
Watanabe M; Nakahata S; Hamasaki M; Saito Y; Kawano Y; Hidaka T; Yamashita K; Umeki K; Taki T; Taniwaki M; Okayama A; Morishita K
J Virol; 2010 Jul; 84(14):6966-77. PubMed ID: 20444901
[TBL] [Abstract][Full Text] [Related]
7. Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells.
Macaire H; Riquet A; Moncollin V; Biémont-Trescol MC; Duc Dodon M; Hermine O; Debaud AL; Mahieux R; Mesnard JM; Pierre M; Gazzolo L; Bonnefoy N; Valentin H
J Biol Chem; 2012 Jun; 287(25):21357-70. PubMed ID: 22553204
[TBL] [Abstract][Full Text] [Related]
8. Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy.
Ishikawa C; Senba M; Mori N
Invest New Drugs; 2021 Apr; 39(2):317-329. PubMed ID: 32959166
[TBL] [Abstract][Full Text] [Related]
9. Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.
Nakagawa M; Schmitz R; Xiao W; Goldman CK; Xu W; Yang Y; Yu X; Waldmann TA; Staudt LM
J Exp Med; 2014 Dec; 211(13):2497-505. PubMed ID: 25488980
[TBL] [Abstract][Full Text] [Related]
10. Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL).
Fukuda R; Hayashi A; Utsunomiya A; Nukada Y; Fukui R; Itoh K; Tezuka K; Ohashi K; Mizuno K; Sakamoto M; Hamanoue M; Tsuji T
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15213-8. PubMed ID: 16217039
[TBL] [Abstract][Full Text] [Related]
11. Anti-adult T‑cell leukemia/lymphoma activity of cerdulatinib, a dual SYK/JAK kinase inhibitor.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2018 Oct; 53(4):1681-1690. PubMed ID: 30066853
[TBL] [Abstract][Full Text] [Related]
12. NF-κB signaling mechanisms in HTLV-1-induced adult T-cell leukemia/lymphoma.
Harhaj EW; Giam CZ
FEBS J; 2018 Sep; 285(18):3324-3336. PubMed ID: 29722927
[TBL] [Abstract][Full Text] [Related]
13. Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.
Rauch DA; Ratner L
Viruses; 2011 Jun; 3(6):886-900. PubMed ID: 21994759
[TBL] [Abstract][Full Text] [Related]
14. Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma.
Ramezani S; Shirdel A; Rafatpanah H; Akbarin MM; Tarokhian H; Rahimi H; Bari A; Jahantigh HR; Rezaee SA
Med Microbiol Immunol; 2017 Aug; 206(4):327-335. PubMed ID: 28466382
[TBL] [Abstract][Full Text] [Related]
15. Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL).
Xu X; Kalac M; Markson M; Chan M; Brody JD; Bhagat G; Ang RL; Legarda D; Justus SJ; Liu F; Li Q; Xiong H; Ting AT
Cell Death Dis; 2020 Feb; 11(2):94. PubMed ID: 32024820
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-κB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
Fauzi YR; Nakahata S; Chilmi S; Ichikawa T; Nueangphuet P; Yamaguchi R; Nakamura T; Shimoda K; Morishita K
PLoS One; 2021; 16(8):e0256320. PubMed ID: 34407152
[TBL] [Abstract][Full Text] [Related]
17. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
[TBL] [Abstract][Full Text] [Related]
18. Degradation of p47 by autophagy contributes to CADM1 overexpression in ATLL cells through the activation of NF-κB.
Sarkar B; Nishikata I; Nakahata S; Ichikawa T; Shiraga T; Saha HR; Fujii M; Tanaka Y; Shimoda K; Morishita K
Sci Rep; 2019 Mar; 9(1):3491. PubMed ID: 30837480
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
[TBL] [Abstract][Full Text] [Related]
20. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
